The National Independent Laboratory Association Logo
  
  • Home
  • Contact
  • Member Login
Register
  • About
  • Advocacy
    • LDTs/VALID Act
    • SALSA/PAMA
    • Advocacy Fund
    • Archived
  • News
  • Membership
    • Membership Benefits
    • Join
    • Renew
    • Vendor Members
  • Meetings
    • Lab Leaders Forum and Mid-Winter Meeting
  • AAB Homepage

FDA Releases New Information on Testing for SARS-CoV-2

The FDA recently made updates to its FAQs on Testing for SARS-CoV-2:

UPDATED the answer to the following question:

  • I am having trouble obtaining viral transport media (VTM) and a flocked nasopharyngeal swab to collect and transport patient samples. Are there alternatives that I can use?

ADDED the following question and answer:

  • What laboratories that had previously provided notification to FDA that they had developed and validated a diagnostic SARS-CoV-2 test under the policy outlined in Section IV.A of the Policy for Coronavirus Disease-2019 Tests have now been removed from that notification list because FDA has determined the test should no longer be used?
  • Membership
    • Membership Benefits
    • Join
    • Renew
    • Vendor Members

NILA News

3/4/2025
NILA Meets for Lab Leaders Forum in San Antonio

1/8/2025
NILA's 2025 Lab Leaders Forum and Mid-Year Meeting to be Held Feb. 28-Mar. 1

10/8/2024
NILA and AAB File an Amicus Brief in Support of the ACLA and AMP Lawsuit Against FDA’s LDT Rule

   

Copyright The National Independent Laboratory Association. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • Home
  • NILA Membership
  • Search
  • Sitemap
  • Contact NILA
  • Return/Cancellation Policy
  • Privacy Policy

The National Independent Laboratory Association
906 Olive Street - Suite 1200, St. Louis, MO 63101-1448, 314-241-1445 - Fax 314-241-1449